IRWD CIK: 1446847

Ironwood Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.75
FY22:
0.78
FY23:
0.23
FY24:
0.18
FY25:
0.27
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.32
FY23:
0.24
FY24:
0.17
FY25:
0.12
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.13
FY22:
1.10
FY23:
0.47
FY24:
0.35
FY25:
0.40

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.16
FY22:
0.03
FY23:
0.28
FY24:
0.04
FY25:
0.24
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.36
FY22:
0.42
FY23:
0.54
FY24:
0.61
FY25:
0.42
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.61
FY22:
0.65
FY23:
−0.35
FY24:
−0.30
FY25:
−0.26
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.13
FY22:
1.10
FY23:
0.47
FY24:
0.35
FY25:
0.40

All amounts in billions USD Data sources:SEC EDGARTwelve Data